A pleasure to publish this at
@CD_AACR
w/some AMAZING
@OncoAlert
🚨colleagues/friends
SoMe has immense potential in ALL areas of medicine⚕️
☑️raises awareness on trials
☑️promotes cancer prevention ☑️amplifies oncology info
☑️enables diverse viewpoints
Just Out
@NEJM
#ASCO22
Randomized Trial of4⃣5⃣5⃣patients sees that;
✅A ctDNA-guided approach to the tx of stage II
#ColonCancer
reduced📉adj chemo use without compromising recurrence-free survival‼️
@OncoAlert
🚨
Hi
@TwitterSupport
the account for
@OncoAlert
🚨has been locked because we updated the birthday to reflect the start of the network March 25, 2019
In doing so our
@TwitterBlue
verified account was locked out due to AGE restrictions
We're an Oncology⚕️Network
⚠️PLEASE RETWEET‼️
Just Presented at
#ASCO22
🌐
Just Published in
@JCO_ASCO
Prospective study of 1⃣0⃣3⃣ patients w/high-risk HR+
#BreastCancer
in late adjuvant setting;
✅ctDNA 🧬was identified a median of1⃣year before ALL cases of distant metastasis‼️
@OncoAlert
🚨
Dear colleagues,
Please join me in welcoming our new
@myESMO
President, our amazing friend & colleague
@peters_solange
Our heartfelt thanks to president
@TaberneroJosep
for his leadership & vision, both indeed a great inspiration for many of us in our society.
Sincerely,
Gil
Just out at
@NEJM
patients w resectable, early-stage
#NSCLC
🫁neoadj pembro🧪plus chemo followed by resection and adjuvant pembro significantly improved event-free survival, major pathological response, and pathological complete response‼️
Last Hour of
#ESMOBreast20
and things are running smoothly here at
@OncoAlert
🚨headquarters.
My little apprentice is ROCKING IT & SUPER proud of his
#OncoAlert
family‼️
Sending our best👱♂️👶
Gil Jr & Sr
That Awesome feeling when you are chilling in the Balcony getting
@oncoalert
ready for
#ASCO21
🇺🇸& your Amazing family reminds you that it’s Swedish🇸🇪National Day & Father’s Day in Lithuania🇱🇹. What’s a boy to do...
#SwedishDadProblems
#LifeisGood
🧁 ☕️
What an AMAZING way to spend a birthday🎂
The worlds BEST wife👩⚕️
The most Amazing son👦
& inside mommys tummy, a Wonderful daughter🤰
The best Birthday gift this year is coming in September‼️
Thank you friends & family for another wonderful year of having you in my life🥰
Gotta love these
@JAMAOnc
Patient Page📰
#immunotherapy
💉Adverse Effects
1️⃣in5️⃣patients on immunotherapy will have an irAE
Things that increase risk include using2️⃣🧪immunotherapy drugs at the same time & having a history of autoimmune disease 🦠
Meanwhile in
#sweden
...Texas’ own Jim Allison accepts the highest price in medicine, the
#NobelPrize
for pioneering
#Immunotherapy
in
#Cancer
treatment. A small honor compared to the countless lives saved & precious family moments patients got to live thanks to his work.KudosJim!
JUST OUT on
@TheLancet
Sacituzumab govitecan💊shows significant survival benefits and manageable safety in comparison to chemotherapy🧪, making it a promising new treatment for patients with pretreated, endocrine-resistant HR+ and HER2– metastatic
#BreastCancer
‼️
@OncoAlert
🚨
Happiest of birthdays to this AWESOME person, our amazing
@OncoAlert
🚨colleague/friend & my Topo-brother
@marklewismd
‼️
Wishing him the best on his day 🎂
Just Out‼️
@US_FDA
🇺🇸approves Enhertu in the tx of unresectable/metastatic HER2-low
#BreastCancer
☑️The 1️⃣st first approved tx targeted 🎯 to HER2-low breast
#mattcancer
JUST OUT
@US_FDA
🇺🇸approved pembrolizumab🧪for adj treatment following resection & platinum-based chemo for stage IB (T2a ≥4 cm), II, or IIIA
#NSCLC
#LungCancer
🫁
Efficacy evaluated in
🔑 KEYNOTE-091
@OncoAlert
🚨
Just Out at
@TheLancetOncol
COSMIC-312 💫
cabozantinib➕ atezolizumab 🆚 sorafenib as 1️⃣st line tx for advanced hepatocellular carcinoma
#HCC
Cabozantinib sees clinical activity in combo w/checkpoint inhibitors♟in solid tumours‼️
@OncoAlert
🚨
One year ago today my little one Gil Jr. was born👶(he is
@OncoAlert
🚨younger brother & spokesperson) After that, life got SO much better!!So in these tough times, LOVE ❤️is there, we just have to be reminded. Happy birthday🥳 my son& cheers to what brings happiness in YOUR life
Just Out at
@NEJM
by our
@OncoAlert
🚨colleague
@DrChoueiri
🇺🇸& Team‼️
Pembrolizumab🧪leads to significant improvement in DFS 🆚 placebo after surgery in patients w/
#kidneycancer
at high risk for recurrence
☑️DFS at 2️⃣4️⃣mo 77.3% 🆚 68.1%
KEYNOTE5️⃣6️⃣4️⃣
Just Out🚨
@US_FDA
🇺🇸approves fixed dose combo of niraparib and abiraterone acetate with prednisone💊in deleterious or suspected deleterious BRCA🧬mutated castration-resistant
#ProstateCancer
.
Efficacy based on the MAGNITUDE 🔎trial
@OncoAlert
Out in
@Annals_Oncology
Study sees evidence of APAP as potential suppressor of antitumor immunity
Acetaminophen💊has been shown to blunt antibody response to vaccination💉
Acetaminophen may impact efficacy of
#immunotherapy
in patients w/
#cancer
🧪
Out on
@TheLancetOncol
🚨Analysis of 4️⃣prospective trials
☑️HER2-low➕tumours can be ID’ed as NEW subgroup of
#BreastCancer
by standardised IHC
☑️HER2-low➕tumours have differences in response to tx💊& prognosis, relevant in tx-resistant, HR➖ tumours
Dear colleagues,
Thank you so very much for these past few days in Barcelona🇪🇸 it has been an 🙌unforgettable
#ESMO19
! A huge round of applause👏 to the
@myESMO
officers and staff that work arduously to make this happen. Sending my best & see you in Madrid‼️
Gil &
@OncoAlert
🚨
As an American🇺🇸practicing medicine in Sweden🇸🇪
I sleep like a baby knowing that my patients will NEVER see this kind of a bill‼️
One of the many reasons I moved to this country I call my 2nd home (after Texas🤠)
#healthcare
for ALL is possible‼️
For anyone doubting that
#healthcare
should be a basic human right, here is a bill for 2
#chemotherapy
treatments. I never smoked, I exercised, I ate healthy before stage IV
#cancer
at age 44. Without insurance, what would I do here? What could I do? I had 55 chemos😞
Just out on
@NatureRevCancer
Making
#cancer
research🔬more inclusive‼️
Diverse voices🗣in our field have potential to enhance, augment & accelerate our ability to close the health disparity gap in cancer & other diseases🌐
#RepresentationMatters
A very important throwback out on
@JAMAOnc
Palliative Care Is the Umbrella ☔️ Not the Rain 🌧
One of the main barriers to early referrals is that patients tend to associate
#PalliativeCare
with hopelessness, cessation of cancer treatment, and death.
Amazing🙌 start to
#ESMO19
Great 👍colleagues🌍, Top science 🧪 & a wonderful Oncology Society🧬. As I look over my Slides, brings a smile to my face knowing I have my family’s support! Shout out to our ♥️families that believe in us & who we can’t wait to get back to!
@OncoAlert
As I return to Sweden 🇸🇪 to my wonderful family 👪after an amazing🙌
#ESMO19
reflection sets in. Thank you
@myESMO
for being a family 👩⚕️👨⚕️all these years, supporting, investing & believing in me. To my wife & son, you are the reason I do anything & what I am is because of you♥️!
This
@NewYorker
cover📰nails
#covid19
on
#DoctorsDay
👩⚕️👨⚕️Most people don’t realize we have families, that we are human, that we also get scared & like you would do anything to protect the ones we love. Please help us & Stay Home 🏡 !!!
JUST OUT‼️
The
@myESMO
Statements for
#COVID19
#vaccination
in
#Cancer
Patients to address Key issues:
✅Efficacy/Safety of the vaccines💉
✅Interactions with Antineoplastic tx🧪
✅Immune Response in patients🦠
✅Distribution & Planning🚛
Dear Colleagues,
I want to thank all y'all for believing🌠in our
@OncoAlert
🚨family from the start. Thanks to all y'all we have accomplished some amazing🙌feats & look forward to what the future has in store for our little network.
Thank you
#OncoAlert
‼️
Sincerely,
Gil
Dear colleagues,
If you‘re at
#ESMO19
🇪🇸next week, I would like to invite✉️ you Sunday 4pm for my presentation “The Oncologist’s role in Prevention” & Monday 11Am for my
@myESMO
YO brunch 🥐session on “Social Media & Oncology”💻
All are cordially invited,
Sincerely,
Gil
Out on📣
@NEJM
📰 KEYNOTE 522 sees addition of pembrolizumab🦠to platinum based neoadjuvant
#chemotherapy
🧪significantly increased 📈the % of patients w/ a pathological complete response among those w/ locally advanced triple-negative
#breastcancer
#TNBC
#BCSM
A heartfelt congratulations to our friend & Colleague
@GlopesMd
who is being recognized by
@ASCO
as a 2019 Fellow of the American Society of Clinical
#Oncology
(
#FASCO
). Thank you for your hard work Gilberto, specially in Global Oncology, you are a true leader in
#cancer
care!
Out on
@JAMAOnc
📰
What are Clinical Outcomes & Toxic Effects of Single Immune Checkpoint Inhibitors🧪in
#GeriOnc
pts❓
Study suggests they can derive benefit👍but w/a lower📉threshold &⬆️higher rate of irAE-related ICI discontinuation w/increasing age
Just out on
@NEJM
📰
@OncoAlert
🚨
The RELATIVITY trial
Sees inhibition of2️⃣immune checkpoints, LAG-3 & PD-1, provided a greater benefit w/PFS 🆚inhibition of PD-1 alone in previously untreated metastatic or unresectable
#melanoma
‼️
Colleagues
In Response to the invasion of Ukraine🇺🇦, the
@OncoAlert
🚨network will be pulling out of ALL collaborations & congresses in Russia
We're non political, but we must take a stand against the injustices & aggression being directed towards Ukraine‼️
Best,
The Network🌐
Just Out on
@TheLancetOncol
from the amazing team of
@tompowles1
@DrChoueiri
& colleagues!
Updated results from KEYNOTE5⃣6⃣4⃣ support the use of adj pembro mono as a SOC for participants w/
#kidneyCancer
w/increased risk of recurrence post nephrectomy‼️
Although I always have my phone at hand, Junior and me had to take a little time out from
#ASCO20
@OncoAlert
🚨tweeting to enjoy the sweeter things in life...I apparently was taking too long with the pic and dessert 🧁 just could not wait.
Happy Saturday y’all !
The Gils
Dear Colleagues,
To think my twitter account started just because I wanted to be more on top of the changes in oncology and be a better doctor👨⚕️for my patients. Since then
@GlobalOncoEdu
&
@OncoAlert
🚨and it’s all been due to your support.
A whole hearted Thank you‼️
Gil
Dear friends,
@OncoAlert
🚨Headquarters are💯% and READY for an exciting
#ASCO21
‼️
Our Junior Faculty has taken over the keyboard, so expect a little more ELMO than what you normally expect from
#OncoAlert
🤠
BIGGEST🙌 News out of
#ESMOAsia19
IMHO
#IMbrave150
Frontline Atezolizumab Plus Bevacizumab Prolongs Survival in
#HCC
w/ a median PFS of 6⃣.8⃣ months in Atezolizumab➕Bevacizumab group vs. 4⃣.3⃣months in the sorafenib group‼️Are we looking at a NEW standard of care⁉️
@OncoAlert
🚨
I remember seeing this photo of our amazing
@OncoAlert
colleague
@itsnot_pink
& her son some time ago & few things have ever moved me that way, the strength & the love shook me. Now that I have met her & see the work she puts in to help others, this impacts a million times more!
❤️ this photo of Julia Maues and her son. Julia, diagnosed with breast cancer during pregnancy, is a mother full of love, hope, gratitude, and fierce advocacy for cancer awareness and research, who inspires us all to do better.
@itsnot_pink
I have been wanting to do this all year, huge shout📣out to 3️⃣ incredible Colleagues who do an amazing job in spreading oncology education & awareness year round.
@jsoriamd
@tmprowell
&
@EricTopol
Thanks for all you do, your colleagues sure do appreciate it‼️
Best,
@OncoAlert
🚨
As a physician I have heard "I smoke, but my lungs are healthy". Here is the difference between healthy lungs and a smokers lungs. Smoking affects lung appearance & physiology (function, lung capacity and oxygen exchange), it is easy to see
#Smokingkills
& damages. End
#tobacco
Live 📣from
#ESMO19
@OncoAlert
just out at🚨
@NEJM
In advanced
#melanoma
, 🦠sustained long-term overall survival at 5 years was observed 🔬in a greater 🙌percentage of patients who received nivolumab + ipilimumab or nivolumab alone than ipilimumab alone,
Just out📣at
@TheLancetOncol
📰Great article on
#Cancer
care in the time of
#COVID19
“The
#coronavirus
outbreak is a rapidly evolving situation & it is placing unprecedented strain on health-care systems” This is a sobering look on the realities we face worldwide 🌎
It is our responsibility to speak out and denounce abuse. Sexual harassment & misuse of power is a pandemic that we face not just in medicine, but in all aspects of life & there are NO excuses for it!
The OncoAlert Network has ZERO tolerance for sexual harassment or abuse of any type & stand by our values. These kinds of actions are inexcusable and we condemn them wholeheartedly!!
Sincerely,
The OncoAlert Network
Just Out (via
@ASCO
Post)
@US_FDA
@FDAOncology
🇺🇸Approves sacituzumab govitecan in unresectable, locally advanced or mets HR positive, HER2-negative🧬
#BreastCancer
who received ET💊 & at least 2⃣additional systemic tx
@OncoAlert
🚨
based on TROPiCS-02
Industry News Release
pembrolizumab🧪+ chemo before surgery shows good results in KEYNOTE-756🔑
First positive Phase3⃣study w
#immunotherapy
, sees significant improvement in pCR rate compared to neoadj placebo + chemo‼️
@OncoAlert
#BreastCancer
#bcsm
One of my all time favorite
#Oncologists
@drdonsdizon
“
#cancer
is a noun, not an adjective...it does not define you” . Dear Colleagues remind your patients daily, this disease has a tendency to make people forget this! Well put Don!
#OncoAlert
Out at
@TheLancetOncol
Addition of chest CT during FU(to clinic visits & chest x-rays after surgery) did not result in longer survival among patients w/
#NSCLC
☑️It did enable the detection of more cases of early recurrence & 2nd primary
#LungCancer
🫁
Dear friends,
The hits keep on coming this
#ESMO21
& we end the final addition to the day by welcoming the newest member of the
#BreastCancer
faculty
A warm welcome to
@DrRBarroso
Medical Oncologist & scholar at Hospital Sírio-Libanês🇧🇷
We Are All🌐
@OncoAlert
🚨
One thing for sure...
#Covid_19
is showing us that the REAL super heroes are not amazing athletes⚽️or the super rich💰but rather the hard working colleagues👩⚕️👨⚕️(ALL working in healthcare)who are in Emergency rooms🚨& ICU🏥units worldwide🌎 working arduously to make a difference‼️
Laughter is indeed the best Medicine😃 Here’s a little of nerd humor to get you through the day 😉 Wishing all of our friends a happy weekend‼️
Best,
@weoncologists
&
@OncoAlert
Perfect timing for
@IASLC
#WCLC19
Just out 📣
@NEJM
editorial📰on the 🌍global epidemic of
#vaping
induced respiratory injuries. Efforts are needed to increase ⬆️public awareness of the harmful effect of vaping & we as👨⚕️👩⚕️physicians should discourage their patients from vaping‼️
Dear
@OncoAlert
colleagues,
On behalf of Gil 👨⚕️& Gil Jr 👶sorry for the delay on our list of the week’s 🙌top
#OncoAlert
contributors. Beach 🏖 got in the way, but will be posted Monday Morning Sweden 🇸🇪 time! Even
@weoncologists
need a vacation 😉
JUST OUT
@US_FDA
🇺🇸Approves elacestrant in postmenopausal women/adult men w/ER➕HER2➖ESR1🧬mutated advanced or metastatic
#BreastCancer
w/disease progression following at least 1️⃣line ET
Decision based on Efficacy in EMERALD💎
@OncoAlert
🚨
@FDAOncology
All going smoothly at
@OncoAlert
🚨 headquarters and enjoying an Awesome last day of
#ASCO20
‼️
I’ve got the best copilot EVER & hes got Elmo 😀
Best,
The Gils
Great Review at
@NatRevClinOncol
Understanding&overcoming resistance to PARP inhibitors in
#cancer
tx 💊
☑️BRCA deficient cells are extremely vulnerable to PARP inhibition
☑️Use of PARP inh currently being expanded to
#prostatecancer
&
#PancreaticCancer
Friends
As director of
@OncoAlert
🚨 I can tell you that there wouldn't be an OncoAlert🌐network if it wasn't for
@DrChoueiri
An Incredible friend, colleague& mentor!
Dr. Choueiri👨⚕️is running in
@ASCO
elections🗳️for the nominating committee& has OUR unconditional support‼️
VOTE
Out at
@ASCO_pubs
🔟yr Outcome of Neoadj
#Chemoradiotherapy
➕Surgery for
#EsophagealCancer
☑️Show OS benefit in locally advanced resectable esophageal or junctional
#Cancer
who receive preop chemorad🧪☢️ According to CROSS, persists at least🔟years‼️
Out on
@TheLancetOncol
Randomised, phase 1b/2 of Nivo or Ipi in adv.
#PancreaticCancer
not progressed after 16 wks platinum Tx
☑️1ry endpoint6️⃣mo PFS Met in the niraparib+ipilimumab maintenance group
Potential for NonCytotoxic maintenance ‼️
@OncoAlert
Just out📣
@TheLancetOncol
📰
KEYNOTE1️⃣5️⃣8️⃣suggests
Tumor mutational burden could be a novel & useful predictive biomarker🎯for response to pembrolizumab🧪monotherapy in previously treated recurrent or metastatic advanced solid tumors
#OncoAlert
🚨